Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study

Abstract

Introduction

Amyotrophic lateral sclerosis (ALS) is an inevitably fatal condition that leads to a progressive loss of physical functioning, which results in a high psychosocial burden and organizational challenges related to medical care. Multidimensional and multiprofessional care is advised to meet the complex needs of patients and their families. Many healthcare systems, including Germany, may not be able to meet these needs because non-medical services such as psychological support or social counselling are not regularly included in the care of patients with ALS (pwALS). Specialised neuropalliative care is not routinely implemented nor widely available. Caregivers of pwALS are also highly burdened, but there is still a lack of support services for them.

Methods

This project aims to assess the perceptions and satisfaction with ALS care in Germany in pwALS and their caregivers. This will be achieved by means of a cross-sectional, multicentre survey. The examination will assess, to which extend the patients’ needs in the six domains of physical, psychological, social, spiritual, practical and informational are being met by current care structures. This assessment will be linked to mental well-being, subjective quality of life, attitudes toward life-sustaining measures and physician-assisted suicide, and caregiver burden. The study aims to recruit 500 participants from nationwide ALS centres in order to draw comprehensive conclusions for Germany. A total of 29 centres, mostly acquired via the clinical and scientific German Network for Motor Neuron Diseases (MND-NET), will take part in the project, 25 of which have already started recruitment.

Perspective

It is intended to provide data-based starting points on how current practice of care in Germany is perceived pwALS and their caregivers and how it can be improved according to their needs. Planning and initiation of the study has been completed.

Trial registration

The study is registered at ClinicalTrails.gov; NCT06418646

Introduction

Amyotrophic lateral sclerosis (ALS) is the most prevalent adult onset motor neuron disease. Currently, over 5,000 people affected by ALS live in Germany [1]. Due to the progressive degeneration of motor neurons, ALS leads to a continuous decline in voluntary muscle functioning, resulting in the loss of mobility as well as in disabilities of speech and swallowing. The impairment of respiratory function due to the involvement of the respiratory muscles usually leads to death within 2-4 years after symptom onset, unless patients opt for invasive ventilation [2].

ALS care is characterised by two central factors, which are closely intertwined:

First, patients’ disease burden, their needs and the corresponding requirements for professional care are dynamic and involve different domains, see Fig. 1 [3]. Psychosocial and socio-medical aspects have significant impact on patients’ QoL: Naturally, health related QoL worsens throughout the disease course, however, patients’ subjective QoL is more strongly associated with psychological factors such as anxiety and depression [4]. In addition, QoL is related to the provision of appropriate medical aids that support patient autonomy and compensate for deficits [5]. Although data is limited, multidimensional, whole-person support has been shown to enhance some aspects of patients’ QoL [6]. Individualised advance care planning is another important issue in ALS care, including decisions about gastrostomy, non-invasive as well as tracheostomy invasive ventilation and cardiopulmonary resuscitation. Advance care planning is recommended to commence timely and be revisited periodically, given that patient preferences may significantly change over time [7]. This process is time consuming and demands a high level of expertise in dealing with the end-stage of ALS, along with sensitivity towards the patient’s background, personality and individual values and beliefs.

Fig. 1

Examples of the needs and suffering of pwALS in six domains, based on the Supportive Care Framework according to Fitch [13]. This model served as basis for the newly developed patient questionnaire

Moreover, it is well-known that family caregivers of patients with ALS (pwALS) experience burden at multiple levels, are highly stressed and sometimes report a lower QoL than the patients themselves [8]. Relief for family caregivers can be provided, for example by access to psychosocial counselling and support, 24/7 availability of support in the event of a sudden crisis, or by setting up respite care if necessary [6].

Given these complex and dynamic requirements, highly specialised, multidimensional and multiprofessional care is required, as outlined in the current ALS treatment guidelines [9]. International studies suggest that this approach offers advantages in terms of survival time, decision-making, QoL and patient satisfaction with care [10,11,12].

Second, as there is still no curative treatment available for ALS, the therapeutic approach is essentially palliative from the time of diagnosis. The primary treatment goal is to alleviate symptom burden and enhance quality of life (QoL) throughout the course of the disease, by providing Palliative Care. Palliative Care is multidimensional by definition and involves the alleviation of as well physical as also psychosocial or spiritual suffering in the context of a life-limiting disease, encompassing the family system and focusing on the individual QoL and needs of both patients and caregivers (Table 1). Basically, the scientific literature advocates the early integration of specialised palliative care (SPC) for individuals who experience a high symptom burden - if necessary from the time of diagnosis [6]. While systematic studies are scarce, SPC is believed to be linked to improved symptom management during the course of the disease and at the end of life. Furthermore, it is associated with better QoL and enhanced communication both with and within the affected families, resulting in positive effects on patient-centred treatment planning in ALS [6, 14,15,16]. For oncological diseases, SPC has also been shown to reduce psychosocial distress such as anxiety and the feeling of being a burden [17]. Meanwhile, the optimal integration of SPC in ALS care remains unclear and standardised pathways for practice have not yet been established. In accordance, the above-cited literature on SPC in ALS describes different arrangements, such as integrating an SPC expert into an ALS-specialised team or systematically referring pwALS to SPC providers, guided by predefined trigger-points. In Germany, specialised outpatient palliative care is the most common way of integrating SPC in ALS care. However, in practice, this is often limited to the last weeks of life, contradicting the ALS treatment guidelines [18,19,20]. The requirements for the involvement of SPC providers, its maximum duration as well as its effectiveness on patient-centred outcomes vary between the federal states of Germany [21].Timely availability, neurological knowledge and awareness of the special needs of pwALS also vary between providers.

Table 1 Definitions of three different specifications of Palliative Care (as mentioned in the text) und potential providers in the context of ALS care in Germany

SPC has so far mainly focused on oncological diseases. Therefore, the new German treatment guidelines for neuropalliative patients specify recommendations for SPC in neurological disorders, termed neuropalliative care (NPC; see table 1), taking into account the specific needs of patients with neurological diseases. However, apart from a few flagship projects (https://neurologie.charite.de/leistungen/klinische_schwerpunkte/neuropalliativecare/; https://www.khagatharied.de/die-medizin-2/neurologie/als-home-care/), NPC structures are not yet established in Germany. Specialised ALS centres are mentioned as providers of NPC in the guidelines, provided that they have experience in caring for patients in their last phase of life [20].

In practice, ALS centres devote a great amount of time to NPC, including repetitive counselling with regard to end-of-life decisions, advance care planning, and provision of appropriate pharmacological symptom treatment and medical aids, complemented by unscheduled telephone- or video-calls in case of crisis and the provision of emotional support. However:

• 1. Special qualifications in palliative care are not mandatory and the level of individual experience varies

• 2. Structural and personnel requirements for treating patients with a high and possibly dynamically exacerbating palliative symptom burden are not given, such as 24/7 availability of the team or the possibility of home visits when needed

• 3. Most importantly, adequate cost-effective compensation for these services is not provided, particularly since non-medical professions are completely excluded from the reimbursement process – in crucial contrast to Specialised outpatient palliative care.

In summary, there are large discrepancies between the current standard care structures in Germany and the well-known imperative for multidimensional, palliative care of pwALS and their caregivers. Neither the multidimensionality of patients’ needs is displayed in standard care, as non-medical services such as psychological support or social counselling are not regularly included or can be reimbursed; nor is the need for medically specialised NPC. Additionally, there is a lack of support services for caregivers.

International studies suggest that subjective deficiencies in care can significantly impact the well-being of patients: they mediate the relationship between disease severity and QoL [22] and have an impact on decision-making regarding life-prolonging measures [23]. In an interview study, a large proportion of caregivers reported deficits in the professional care provided, which was associated with stronger caregiver burden and health impairments–some of which persist for years after the patients’ death [18, 24]. Furthermore, psychological well-being of caregivers is an important factor influencing if patients can live and be cared for at their home [6, 8]. Finally, yet importantly, a legal regulation of physician-assisted suicide is currently being discussed in Germany–an option that necessitates optimised and accessible palliative care services at the same time [25]. This is crucial to avoid suicides committed as a consequence of physical or psychological suffering that could be at least partially alleviated.

Methods

Aim of the study

The primary aim of the project is to investigate how pwALS and their caregivers perceive and are satisfied with different aspects of ALS care in Germany, focusing on their potential needs in the six domains displayed in Fig. 1. So far, it has not been recorded systematically to what extent the structural weaknesses of ALS care in Germany described above are reflected in the subjective perceptions of those affected. The results of the study may provide data-based starting points on improving the structural aspects of care for pwALS and their caregivers in Germany–in order to align care more closely with their needs and prevent harm. Furthermore, insights into potential associations between the perception of weak points of care and mental health, QoL, attitudes towards life-prolonging measures and physician assisted suicide and caregiver burden may provide political arguments to improve care structures in Germany toward a more holistic perspective, emphasising the above-mentioned palliative treatment goals.

Study description and study design

The aim of the study is to be achieved through a prospective, cross-sectional, multi-centre-study, based on paper-pencil-questionnaires for pwALS and their family caregivers. Study planning was conducted at the specialised outpatient clinic for motor neuron diseases of the University Hospital Carl Gustav Carus at the Technische Universität Dresden. Recruitment will mainly be done via the German Network for Motor Neuron Diseases (https://mnd-net.de), which our centre is a member of, potential collaboration partners were consecutively invited to contribute to the study. To date, 25 sites have already initiated and started recruitment, and another four sites have expressed informal commitments to participate in the study, with local ethical approval or cooperation agreement still pending (see Fig. 2). We aim to include a total of 500 pwALS by the end of 2024. Since this study has an explorative character, no statistical sample size calculation was conducted. The sample size is limited by the number of available patients who will be examined or treated in the participating ALS centres during the study period and who consent to study participation.

Fig. 2

German ALS-centres involved in the project, mainly recruited from the German Network for Motor Neuron Diseases (MND-NET; https://mnd-net.de)

Assessment instruments

The survey instruments for this study comprise four paper-pencil questionnaires, described in detail in Table 2.

Table 2 Description of the four questionnaires deployed in this study

The section of the patient questionnaire that asks about patients’ needs and corresponding support was designed specifically for this project. Item selection was based on extensive literature search and pre-tested for comprehensibility.

Questionnaires for treating physician, patient and caregiver, related to a specific patient, are linked by a shared code that allows them to be assigned to each other.

Recruitment of participants and eligibility criteria

As a first step, the treating neurologist personally informs eligible patients and their accompanying caregivers about the possibility to participate in the study during their outpatient or inpatient stay. If they provide consent, they receive detailed information and are subsequently enrolled in the study. Once consent has been obtained, participants receive the questionnaires to complete on their own and then send them back to the study centre Dresden, using postage-paid return envelopes. Patients who are physically unable to complete the questionnaire on their own are asked to seek assistance from a related person.

Inclusion criteria

• 1. At least “possible ALS“ according to the revised El-Escorial-criteria (all disease stages; all subtypes)

• 2. Age of ≥ 18 years

• 3. No impairments of behaviour or mental performance relevant to everyday life that limit the ability to make judgments or give consent (e.g. as part of a comorbid frontotemporal dementia or another severe disease such as schizophrenia or delirium)

Data analysis

The needs of patients in the above-mentioned six domains (Fig. 1) and their perception of professional care will be analysed descriptively. Additionally, the following research questions will be investigated:

• Are subjective deficiencies in professional support associated with psychological well-being and QoL, attitudes towards life-sustaining measures or physician-assisted suicide among pwALS or caregivers, or with caregiver burden?

• How frequently are non-medical actors (social workers, etc.) and SPC involved?

• Is subjective satisfaction with care associated with certain patient-side factors (e.g. gender, disease severity, urban or rural living environment)?

• Is subjective satisfaction with care associated with factors on the part of the ALS centres?

These questions will be investigated using correlation analysis and comparison tests (depending on level of data and statistical prerequisites). For statistical analysis we will use SPSS 23.0 software.

Contacts

This study was initiated at the University Hospital Carl Gustav Carus at Technische Universität Dresden. PD Dr. med. habil. René Günther and Dr. rer. medic. Katharina Linse are PIs of the study. The project is funded by the German Society of Muscle Diseases (Deutsche Gesellschaft für Muskelkranke e.V.) and by a seed grant of the ALS association. Additionally, the study received support by ITF Pharma GmbH and Zambon GmbH.

Perspectives

There is a large disparity between the multiple, complex and dynamic needs of pwALS and the German care structures for ALS, considering the palliative situation and the consequent focus on patients’ QoL. From a theoretical point of view and based on the experience of professionals engaged in ALS care, it appears evident, that there is a need for further development in ALS care. To the best of our knowledge, this study is the first systematic assessment of patients’ perception of and satisfaction with different domains of ALS care and of potential associations with mental health, QoL, attitudes towards life-prolonging measures and physician assisted suicide, and caregiver burden. Strengths of the study include its multi-centre approach, the potential of a high, nationwide caseload, and the possibility of deriving quantitative statements. It may provide valuable data on the perspectives of those affected, identifying the focal points that are most important to them and do have the largest impact on their wellbeing. The overriding goal is to design a concept that incorporates structural changes contributing to a more need-driven, whole-person, multidimensional and multiprofessional care for these vulnerable patients and their caregivers. This is essential to effectively match both the needs of pwALS and their caregivers, thereby avoiding insufficient of care as well as both mis- and overprovision.